According to iBio's latest financial reports and stock price the company's current Operating Margin is -6,863.55%. At the end of 2024 the company had an Operating Margin of -6,863.56%.
Year | Operating Margin | Change |
---|---|---|
2024 | -6,863.56% | |
2022 | -1,566.51% | 60% |
2021 | -979.04% | -2.48% |
2020 | -1,003.91% | 15.13% |
2019 | -872.00% | -75.96% |
2018 | -3,627.93% | -11.43% |
2017 | -4,096.19% | 264.38% |
2016 | -1,124.16% | 214.08% |
2015 | -357.91% | -79.99% |
2014 | -1,788.29% | 190.55% |
2013 | -615.49% | 38.47% |
2012 | -444.48% | -76.06% |
2011 | -1,856.25% | |
2009 | -161.97% | -14.3% |
2008 | -189.00% | 1.73% |
2007 | -185.79% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
![]() | -1,084.89% | -84.19% | ๐บ๐ธ USA |
![]() | -14.09% | -99.79% | ๐บ๐ธ USA |
![]() | 18.78% | -100.27% | ๐บ๐ธ USA |
![]() | -121.10% | -98.24% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.